David Colleran
CIK: 0001646558
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Anika Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Mar 15, 2026ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct6.4K shares- - Mar 15, 2026ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct1.9K shares at avg. $14.20$27K - Mar 14, 2026ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct9.4K shares- - Mar 14, 2026ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct4.2K shares at avg. $14.20$59K - Mar 14, 2026ANIK
Anika Therapeutics, Inc.
Award(A)Direct4.7K shares- - Mar 9, 2026ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct1.9K shares at avg. $14.96$29K - Mar 9, 2026ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct5.5K shares- - Mar 17, 2025ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct1.9K shares at avg. $15.91$30K - Mar 17, 2025ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct6.4K shares- - Mar 14, 2025ANIK
Anika Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
13.7K shares- - Mar 14, 2025ANIK
Anika Therapeutics, Inc.
Award(A)DirectRestricted Stock Unit
28.2K shares- - Mar 11, 2025ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct7.7K shares- - Mar 11, 2025ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct2.3K shares at avg. $16.79$38K - Mar 10, 2025ANIK
Anika Therapeutics, Inc.
Tax Payment(F)Direct1.6K shares at avg. $16.62$27K - Mar 10, 2025ANIK
Anika Therapeutics, Inc.
Exercise(M)Direct5.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 15, 2026 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 6,449 | - | $0 | Direct |
| Mar 15, 2026 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 1,893 | $14.20 | $26,881 | Direct |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 9,388 | - | $0 | Direct |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 4,168 | $14.20 | $59,186 | Direct |
| Mar 14, 2026 | ANIK Anika Therapeutics, Inc. | Award(A) | 4,694 | - | $0 | Direct |
| Mar 9, 2026 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 1,919 | $14.96 | $28,708 | Direct |
| Mar 9, 2026 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 5,465 | - | $0 | Direct |
| Mar 17, 2025 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 1,893 | $15.91 | $30,118 | Direct |
| Mar 17, 2025 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 6,448 | - | - | Direct |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | Award(A) Restricted Stock Unit | 13,669 | - | - | Direct |
| Mar 14, 2025 | ANIK Anika Therapeutics, Inc. | Award(A) Restricted Stock Unit | 28,165 | - | - | Direct |
| Mar 11, 2025 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 7,663 | - | - | Direct |
| Mar 11, 2025 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 2,250 | $16.79 | $37,778 | Direct |
| Mar 10, 2025 | ANIK Anika Therapeutics, Inc. | Tax Payment(F) | 1,604 | $16.62 | $26,658 | Direct |
| Mar 10, 2025 | ANIK Anika Therapeutics, Inc. | Exercise(M) | 5,465 | - | - | Direct |
1-15 of 15 transactions
About Colleran David
Colleran David (SEC CIK 0001646558) files insider reports with the SEC as EVP, General Counsel, Corp Sec of Anika Therapeutics, Inc. (ANIK).
Signal8 holds 5 ownership filings by Colleran David, all Form 4s, filed between Mar 11, 2025 and Mar 17, 2026. Those filings report 15 transactions, from Mar 10, 2025 to Mar 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Colleran David's filings is in BEDFORD, MA.
Recent filings by Colleran David
- Mar 15, 2026: Option exercise of ANIK shares (Form 4, code M).
- Mar 15, 2026: Tax withholding of ANIK shares (Form 4, code F).
- Mar 14, 2026: Option exercise of ANIK shares (Form 4, code M).
- Mar 14, 2026: Tax withholding of ANIK shares (Form 4, code F).
- Mar 14, 2026: Grant or award of ANIK shares (Form 4, code A).
Other insiders filing for Anika Therapeutics, Inc. (ANIK)
- Fischetti Gary P, Director
- HENNEMAN JOHN B III, Director
- Richard Stephen, Director
- Capper Joseph H, Director
- CONLEY SHERYL L, Director
- Griffin Stephen D., President and CEO